Skip to main content
hpa logo
Topics A-Z:
Search the site:
Home › Topics › Infectious Diseases › Infections A-Z › Tularemia (Deliberate Releases) ›Guidance ›  References
Printer friendly page (opens in new window)

References

  1. Abd H, Johansson T, Golovliov I, Sandström G, Forsman M. Survival and growth of Francisella tularensis in Acanthamoeba castellani. Appl Environ Microbiol 2003; 69(1): 600-606.
  2. Centre for infectious disease research and policy (CIDRAP) University of Minnesota. Tularemia: Current, comprehensive information on pathogenesis, microbiology, epidemiology, diagnosis, treatment, and prophylaxis. (Last updated April 2, 2009). http://www.cidrap.umn.edu/cidrap/content/bt/tularemia/biofacts/tularemiafactsheet.html
  3. Dennis DT, Inglesby TV, Henderson DA. tularemia as a Biological Weapon. Medical and public health management. JAMA 2001; 285(21) 2763-73.
  4. Feldman KA, Stiles-Enos D, Julian K, Matyas BT, Telford SR, Chu MC, Petersen LR, Hayes EB. Tularemia on Martha's Vineyard: Seroprevalence and occupational risk. Emerg Infect Dis 2003; 9(3): 350-354.
  5. Griffin KF, Oyston PCF, Titball RW. Francisella tularensis vaccines. FEMS Immunol Microbiol 2007; 49: 315-323.
  6. Health aspects of chemical and biological weapons. Geneva, Switzerland: World Health Organization; 1970. p105-7.
  7. Johansson A, Berglund L, Gothefors L, et al. Ciprofloxacin for treatment of tularemia in children. Pediatr Infect Dis J 2000; 19(5): 449-53
  8. Kaufmann AF, Meltzer MI, Schmid GP. The economic impact of a bioterrorist attack: are prevention and post-attack intervention programs justifiable? Emerg Infect Dis 1997;3:83-94.
  9. McCrumb FR Jr. Aerosol infection in man with Pasteurella tularensis. Bacteriol Rev 1961;25:262-7.
  10. Oyston PCF. Francisella tularensis: unravelling the secrets of an intracellular pathogen. J Med Microbiol 2008; 57: 921-30. 
  11. Pearson AP. Tularemia. In: Palmer FR, Lord Sousby Simpson DIH, editors. Zoonoses: biology, clinical practice and public health control. Oxford University Press, 1998. p267-80.
  12. Pearson AP. Franciscella and tularemia . In: Smith GR and Easmon CSF, editors. Topley and Wilson's Microbiology and Microbial infections. 8th ed. London; Arnold; 1990. Vol 2 p595-7, vol 3 p389-92.
  13. Pearson AP. Yersiniosis, pasteurellosis and tularemia. In: Weatherall DJ, Ledingham JGG, Warrell DA, editors. Oxford Textbook of Medicine. 3rd. ed.. Oxford University Press; Oxford; 1996. p599-612.
  14. Perez-Castrillon, JL, Bachiller-luque P, Martin-Luquero M, Mena-Martin J, Herreros V. tularemia epidemic in Northwestern Spain: clinical description and therapeutic response. CID 2001;33:573-6
  15. Sawyer WD, Dangerfield HG, Hogge AL, Crozier D. Antibiotic prophylaxis and therapy of airborne tularemia. Bacteriol Rev 1966;30:542-8.
  16. Steward J, Piercy T, Lever MS, Simpson AJH, Brooks TJG. Treatment of murine pneumonic Francisella tularensis infection with gatifloxacin, moxifloxacin or ciprofloxacin. Int J Antimicrob Agents 2006; 27:439-43.
  17. Tomaso H, Al Dahouk S, Hofer E, Splettstoesser WD, Treu TM, Dierich MP, Neubauer H. Antimicrobial susceptibilities of Austrian Francisella tularensis holarctica biovar II strains. Int J Antimicrob Agents 2005; 26: 279-84.

Last reviewed: 9 November 2009